QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
This Quarter Return
+61.82%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
–
10 Year Return
–
AUM
$68.8M
AUM Growth
+$68.8M
(-4.4%)
Cap. Flow
-$5.72M
Cap. Flow
% of AUM
-8.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Ventyx Biosciences
VTYX
|
$5.72M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ventyx Biosciences
VTYX
$171M
| $26.1M | 37.85% | 746,370 -163,936 | -18% | -$5.72M |
|
|
ICVX
2
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $11.1M | 16.11% | 3,510,228 | – | – |
|
3
HilleVax
HLVX
$105M
| $9.55M | 13.87% | 558,923 | – | – |
|
4
Tourmaline Bio
TRML
$601M
| $7.71M | 11.2% | 2,932,606 | – | – |
|
5
Kezar Life Sciences
KZR
$28.9M
| $7.14M | 10.36% | 828,711 | – | – |
|
6
Jasper Therapeutics
JSPR
$45.5M
| $4.62M | 6.71% | 5,852,982 | – | – |
|
|
ELEV
7
DELISTED
Elevation Oncology
ELEV
| $2.68M | 3.89% | 2,370,142 | – | – |
|